BAYESIAN APPROACH TO NONINFERIORITY TRIALS FOR PROPORTIONS

被引:22
作者
Gamalo, Mark A. [1 ]
Wu, Rui [2 ]
Tiwari, Ram C. [1 ]
机构
[1] US FDA, Off Biostat, Silver Spring, MD 20993 USA
[2] Univ Connecticut, Dept Stat, Storrs, CT 06269 USA
关键词
Bayesian criterion; Bayesian paradigm; Beta-binomial; Noninferiority margin; Normal approximation; STATISTICAL-METHODS; PLACEBO; ISSUES;
D O I
10.1080/10543406.2011.589646
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Noninferiority trials are unique because they are dependent upon historical information in order to make meaningful interpretation of their results. Hence, a direct application of the Bayesian paradigm in sequential learning becomes apparently useful in the analysis. This paper describes a Bayesian procedure for testing noninferiority in two-arm studies with a binary primary endpoint that allows the incorporation of historical data on an active control via the use of informative priors. In particular, the posteriors of the response in historical trials are assumed as priors for its corresponding parameters in the current trial, where that treatment serves as the active control. The Bayesian procedure includes a fully Bayesian method and two normal approximation methods on the prior and/or on the posterior distributions. Then a common Bayesian decision criterion is used but with two prespecified cutoff levels, one for the approximation methods and the other for the fully Bayesian method, to determine whether the experimental treatment is noninferior to the active control. This criterion is evaluated and compared with the frequentist method using simulation studies in keeping with regulatory framework that new methods must protect type I error and arrive at a similar conclusion with existing standard strategies. Results show that both methods arrive at comparable conclusions of noninferiority when applied to a modified real data set. The advantage of the proposed Bayesian approach lies in its ability to provide posterior probabilities for effect sizes of the experimental treatment over the active control.
引用
收藏
页码:902 / 919
页数:18
相关论文
共 50 条
  • [1] Bayesian methods for the design and analysis of noninferiority trials
    Gamalo-Siebers, Margaret
    Gao, Aijun
    Lakshminarayanan, Mani
    Liu, Guanghan
    Natanegara, Fanni
    Railkar, Radha
    Schmidli, Heinz
    Song, Guochen
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2016, 26 (05) : 823 - 841
  • [2] Assessing noninferiority in a three-arm trial using the Bayesian approach
    Ghosh, Pulak
    Nathoo, Farouk
    Goenen, Mithat
    Tiwari, Ram C.
    STATISTICS IN MEDICINE, 2011, 30 (15) : 1795 - 1808
  • [3] Bayesian Design of Noninferiority Trials for Medical Devices Using Historical Data
    Chen, Ming-Hui
    Ibrahim, Joseph G.
    Lam, Peter
    Yu, Alan
    Zhang, Yuanye
    BIOMETRICS, 2011, 67 (03) : 1163 - 1170
  • [4] Bayesian approach to non-inferiority trials for normal means
    Gamalo, M. Amper
    Wu, Rui
    Tiwari, Ram C.
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2016, 25 (01) : 221 - 240
  • [5] Covariate Effect on Constancy Assumption in Noninferiority Clinical Trials
    Xu, Siyan
    Barker, Kerry
    Menon, Sandeep
    D'Agostino, Ralph B.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2014, 24 (06) : 1173 - 1189
  • [6] Three-Arm Noninferiority Trials with a Prespecified Margin for Inference of the Difference in the Proportions of Binary Endpoints
    Hida, Eisuke
    Tango, Toshiro
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2013, 23 (04) : 774 - 789
  • [7] Choice of δ noninferiority margin and dependency of the noninferiority trials
    Tsong, Yi
    Zhang, Joanne
    Levenson, Mark
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2007, 17 (02) : 279 - 288
  • [8] Reporting of noninferiority trials was incomplete in trial registries
    Dekkers, Olaf M.
    Soonawala, Darius
    Vandenbroucke, Jan P.
    Egger, Matthias
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2011, 64 (09) : 1034 - 1038
  • [9] Pros and Cons of Noninferiority Trials
    Ofori, Sandra
    Tornberg, Sara V.
    Kilpelainen, Tuomas P.
    Tikkinen, Kari A. O.
    Guyatt, Gordon H.
    Witte, Lambertus P. W.
    EUROPEAN UROLOGY FOCUS, 2023, 9 (05): : 711 - 714
  • [10] Likelihood ratio and a Bayesian approach were superior to standard noninferiority analysis when the noninferiority margin varied with the control event rate
    Kim, MY
    Xue, XN
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2004, 57 (12) : 1253 - 1261